RecruitingPhase 3NCT05641688
[18F]PI-2620 Phase 3 Histopathological Study
Studying Early-onset autosomal dominant Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Life Molecular Imaging Ltd
- Principal Investigator
- Alireza Atri, MD, PhDBanner Health
- Intervention
- [18F]PI-2620(drug)
- Enrollment
- 200 target
- Eligibility
- 50 years · All sexes
- Timeline
- 2022 – 2027
Study locations (25)
- Barrow Neurological Institute, Phoenix, Arizona, United States
- Banner Sun Health Research Institute, Sun City, Arizona, United States
- UC Los Angeles, Los Angeles, California, United States
- Esperanza Clinical, Murrieta, California, United States
- Sutter Health, San Francisco, California, United States
- Galiz Research, Hialeah, Florida, United States
- UF College of Medicine - Jacksonville, Jacksonville, Florida, United States
- K2 Medical Research, Lady Lake, Florida, United States
- K2 Medical Research, Maitland, Florida, United States
- ClinCloud Research, Melbourne, Florida, United States
- Miami Jewish Health Systems, Miami, Florida, United States
- The Roskamp Institute, Sarasota, Florida, United States
- Charter Research, Winter Park, Florida, United States
- Alzheimer's Disease Center, Braintree, Massachusetts, United States
- Headlands Research, Plymouth, Massachusetts, United States
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05641688 on ClinicalTrials.govOther trials for Early-onset autosomal dominant Alzheimer disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05643144Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesIndiana University
- RECRUITINGNANCT07294885Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's DiseaseGeneral Hospital of Shenyang Military Region
- RECRUITINGNANCT07532590Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content.Casa di Cura Dott. Pederzoli
- ENROLLING BY INVITATIONNCT07314190Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental DisorderFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ENROLLING BY INVITATIONNANCT07425106Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)Duke University
- RECRUITINGPHASE1NCT07328451A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's DiseaseDenali Therapeutics Inc.
- RECRUITINGPHASE1NCT07234942A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Hoffmann-La Roche
- RECRUITINGNCT07207642Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected LivingCentre Hospitalier Universitaire de Saint Etienne
See all trials for Early-onset autosomal dominant Alzheimer disease →